BROSSARD, QUEBEC — (Marketwired) — 06/16/15 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, is pleased to announce the leading results for the automated detection of dark lesions (microaneurysms and bleeding) related to the presence of diabetic retinopathy.Innovative algorithms for detecting retinal microaneurysms and
BROSSARD, QUEBEC — (Marketwired) — 05/27/15 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today a strategic alliance with Centro Diagnostico Angeles.Centro Diagnostico Angeles, part of Grupo Angeles Servicios de Salud, is a diagnostic center located in Mexico City, created to outsource health services for ma
BROSSARD, QUEBEC — (Marketwired) — 05/19/15 — Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announced today an agreement with Digital Angiography Reading Center (DARC).DARC, a retina image analysis center located in New York, has signed a deal with a large U.S. pharmaceutical company for a clinical trial focusing on r
BROSSARD, QUEBEC — (Marketwired) — 05/04/15 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today a licensing deal with Inb al Haythem Center in Algeria.Inb al Haythem Center provides contact lenses and ophthalmic surgery in Algiers, Algeria. DIAGNOS will be providing its proprietary telemedicine software, CAR
BROSSARD, QUEBEC — (Marketwired) — 04/14/15 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today a deal with Clinique Hamouche in Algeria.Clinique Hamouche provides vision correction, eye surgery, plastic surgery, and various other related services and offers the latest laser technologies for the ophthalmolog
BROSSARD, QUEBEC — (Marketwired) — 04/09/15 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today a retina screening project with Clinique Chifa Hydra in Algeria.Clinique Chifa Hydra, owned by Dr. A. Larbaoui, is one of the largest private clinics in Algeria. The clinic prides itself on its use of sophisticate
BROSSARD, QUEBEC — (Marketwired) — 03/26/15 — Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announced today a renewal of the agreement originally announced on March 14th 2012 that has since been renewed and expanded to a total of fourteen mobile screening units. The value of the two year agreement is approximately 716
BROSSARD, QUEBEC — (Marketwired) — 03/18/15 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announced today the signing of a contract with a large global pharmaceutical company that markets a leading ophthalmology product indicated for a variety of ophthalmic complications, including those associated with diabetes, fo
BROSSARD, QUEBEC — (Marketwired) — 03/10/15 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), leader in diabetic retinopathy screening, is announcing the close of a commercial agreement to provide retina screening services to patients in the United States. The sponsor of the services is a major U.S.-based pharmaceutical company that markets a leading ophthalmology product indicated for a variety of ophthalmic complications including those associated wit
BROSSARD, QUEBEC — (Marketwired) — 03/05/15 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), an innovative leader in healthcare services, announces today a strategic restructuring of its business in response to unfavorable market conditions and evolving opportunities. DIAGNOS is planning headcount reductions, primarily in its Mining division, in order to eliminate operating costs related to that division while focusing exclusively on enhancing its Heal
